半胱氨酸蛋白酶抑制劑3(Cys-C)真核蛋白
Eukaryotic Cystatin C (Cys-C)
CST3; Cystatin 3; Gamma Trace; Post-Gamma-Globulin; Neuroendocrine Basic Polypeptide; Amyloid Angiopathy And Cerebral Hemorrhage
- 編號EPA896Hu61
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源真核表達
- 宿主293F cell
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量15.0kDa
- 實際分子量16kDa(差異分析請參閱說明書)
- 片段與標簽Ser27~Ala146 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點8.6
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1680¥ 4200¥ 8400¥ 25200¥ 63000
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體 | WB; IHC; ICC/IF |
| LAA896Hu71 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC |
| MAA896Hu23 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA896Hu27 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC; ICC; IP. |
| RAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. |
| RAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. |
| MAA896Hu24 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC; ICC/IF |
| MAA896Hu25 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB |
| MAA896Hu26 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB |
| MAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB,IHC |
| LAA896Hu74 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA896Hu76 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| FAA896Hu54 | 抗半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(別藻藍蛋白標記) | FCM |
| SEA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies[Hindawi: 740105] |
| Critical Care | Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein[Pubmed:25261195] |
| РОЛЬ АПОПТОЗ ИНДУЦИРУЮЩЕГО ФАКТОРА И ОКИСЛИТЕЛЬНОГО СТРЕССА ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ[616-005.8] | |
| Journal of Agricultural and Food Chemistry | Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice[pubmed:29254330] |
| THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | Association of cathepsin B and cystatin C with an age-related pulmonary subclinical state in a healthy Chinese population[Pubmed: 32401159] |
| RSC Adv | SERS based Y-shaped aptasensor for early diagnosis of acute kidney injury[Pubmed:35733690] |
| Food Funct | A Compared Study of Gentle Ketogenic Diet Containing Medium-Chain Triglycerides or Long-Chain Triglycerides on Chronic Sleep Deprivation-Induced Cognitive?…[Pubmed:35141738] |